Hypertension treatment in a medicare population: Adherence and systolic blood pressure control

Clinical Therapeutics

Volumn 29, Issue 5, 2007, Pages 972-984

  Fung, Vicki ^a,d   Huang, Jie ^a,d   Brand, Richard ^b,d   Newhouse, Joseph P ^c,d,e   Hsu, John ^a,d  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

adherence; blood pressure control; hypertension; pharmacy data; quality of health care

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT COMPLIANCE; PHARMACY; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC ANTAGONISTS; AGED; ANALYSIS OF VARIANCE; BLOOD PRESSURE; COHORT STUDIES; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICARE; ODDS RATIO; PATIENT COMPLIANCE; SOCIOECONOMIC FACTORS; THIAZIDES;

EID: 34547666983     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.05.010     Document Type: Article

References (39)

1. [published correction appears in JAMA. 2003;290: 197]. Chobanian A.V., Bakris G.L., Black H.R., et al., National Heart, Lung, and Blood Institute Joint National Committee (JNC) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289 (2003) 2560-2572
2. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003) 199-206
3. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265 (1991) 3255-3264
4. Neal B., MacMahon S., Chapman N., and Blood Pressure Lowering Treatment Trialists' Collaboration. Effects ofACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials. Lancet 356 (2000) 1955-1964
5. In: McClellan M.B., and Kessler D.P. (Eds). Technological Change in Health Care: A Global Analysis of Heart Attack (2003), University of Michigan Press, Ann Arbor, Mich
6. Moser M., and Setaro J.F. Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med 355 (2006) 385-392
7. Garg J.P., Elliott W.J., Folker A., et al. Resistant hypertension revisited: A comparison of two university-based cohorts. Am J Hypertens 18 (2005) 619-626
8. Monane M., Bohn R.L., Gurwitz J.H., et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population-based study in the elderly. Am J Hypertens 10 (1997) 697-704
9. Schroeder K., Fahey T., and Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 164 (2004) 722-732
10. Bramley T.J., Gerbino P.P., Nightengale B.S., and Frech-Tamas F. Relationship of blood pressure control to adherence with anti hypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 12 (2006) 239-245
11. [published corrections appear in JAMA. 2003;289:178 and JAMA. 2004;291:2196]. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Anti hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensinconverting enzyme inhibitor or calcium channel blocker vs diuretic: The Anti hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002) 2981-2997
12. Steiner J.F., Fihn S.D., Blair B., and Inut T.S. Appropriate reductions in compliance among well-controlled hyper tensive patients. J Clin Epidemiol 44 (1991) 1361-1371
13. Choo P.W., Rand C.S., Inui T.S., et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to anti hypertensive therapy. Med Care 37 (1999) 846-857
14. Grant R.W., Singer D.E., and Meigs J.B. Medication adherence before an increase in anti hypertensive therapy: A cohort study using pharmacy claims data. Clin Ther 27 (2005) 773-781
15. Van Wijk B.L., Klungel O.H., Heerdink E.R., and de Boer A. Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation. J Clin Epidemiol 59 (2006) 11-17
16. Chapman R.H., Benner J.S., Petrilla A.A., et al. Predictors of adherence with anti hypertensive and lipid-lowering therapy. Arch Intern Med 165 (2005) 1147-1152
17. Pladevall M., Williams L.K., Potts L.A., et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 27 (2004) 2800-2805
18. Iskedjian M., Einarson T.R., MacKeigan L.I.D., et al. Relationship between daily dose frequency and adherence to anti hypertensive pharmacotherapy: Evidence from a meta-analysis. Clin Ther 24 (2002) 302-316
19. Van Wijk B.L., Klungel O.H., Heerdink E.R., and de Boer A. The association between compliance with antihyper tensive drugs and modification of anti hypertensive drug regimen. J Hypertens 22 (2004) 1831-1837
20. Kaiser Permanente Care Management Institute's Hypertension Guidelines Workgroup. Evidence-Based Guidelines for the Management of Hypertension (2005), Kaiser Permanente, Oakland, Calif
21. Alexander M., Tekawa I., Hunkeler E., et al. Evaluating hypertension control in a managed care setting. Arch Intern Med 159 (1999) 2673-2677
22. Selby J.V., Fireman B.H., Lundstrom R.J., et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med 335 (1996) 1888-1896
23. [published correction appears in Arch Intern Med. 1998; 158:573]. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157 (1997) 2413-2446
24. Izzo Jr. J.L., Levy D., and Black H.R. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension 35 (2000) 1021-1024
25. Lloyd Jones D.M., Evans J.C., Larson M.G., et al., Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Hypertension 34 (1999) 381-385
26. Wang J.G., Staessen J.A., Franklin S.S., et al. Systolic and diastolic blood pressure lowering as determinants of car diovascular outcome. Hypertension 45 (2005) 907-913
27. Krieger N., and Gordon D. Re: "Use of census-based aggregate variables to proxy for socioeconomic group: Evidence from national samples". Am J Epidemiol 150 (1999) 892-896
28. Krieger N. Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health 82 (1992) 703-710
29. Subramanian S.V., Chen J.T., Rehkopf D.H., et al. Comparing individualand area-based socioeconomic mea sures for the surveillance of health disparities: A multilevel analysis of Massachusetts births, 1989-1991. Am J Epidemiol 164 (2006) 823-834
30. Ash A.S., Ellis R.P., Pope G.C., et al. Using diagnoses to describe populations and predict costs. Health Care Financ Rev 21 (2000) 7-28
31. Ash A.S., Zhao Y., Ellis R.P., and Schlein Kramer M. Finding future high-cost cases: Comparing prior cost versus diagnosis-based methods. Health Serv Res 36 (2001) 194-206
32. Pope G.C., Kautter J., Ellis R.P., et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. . Health Care Financ Rev 25 (2004) 119-141
33. Phillips L.S., Branch W.T., Cook C.B., et al. Clinical inertia. Ann Intern Med 135 (2001) 825-834
34. Reed M., Fung V., Brand R., et al. Care-seeking behavior in response to emergency department copayments. Med Care 43 (2005) 810-816
35. Berlowitz D.R., Ash A.S., Hickey E.C., et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 339 (1998) 1957-1963
36. discussion 1410. Caetano P.A., Lam J.M., and Morgan S.G. Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization. Clin Ther 28 (2006) 1411-1424
37. Osterberg L., and Blaschke T. Adherence to medication. N Engl J Med 353 (2005) 487-497
38. Psaty B.M., Manolio T.A., Smith N.L., et al., Cardiovascular Health Study. Time trends in high blood pressure control and use ofantihypertensive medications in older adults: The Cardiovascular Health Study. Arch Intern Med 162 (2002) 2325-2332
39. DiTusa L., Luzier A.B., Jarosz D.E., et al. Treatment of hypertension in a managed care setting. Am J Manag Care 7 (2001) 520-524